NeuroSense Therapeutics L... (NRSNW)
NASDAQ: NRSNW
· Real-Time Price · USD
0.38
-0.15 (-28.29%)
At close: Sep 11, 2025, 2:49 PM
NeuroSense Therapeutics Revenue
NeuroSense Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, NeuroSense Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
17
Market Cap
9.35M
Revenue Chart
History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 0 | n/a |
Dec 31, 2023 | 0 | n/a |
Dec 31, 2022 | 0 | n/a |
Dec 31, 2021 | 0 | n/a |
Dec 31, 2020 | 0 | n/a |
Dec 31, 2019 | 0 | n/a |